Healthcare provider profile · identity verified

Ashley Kumar, DNP, AGNP-C

Nurse Practitioner · MINNEAPOLIS, MN · NPI 1922725605

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	345	33
Furosemide	Furosemide	247	40
Amlodipine Besylate	Amlodipine Besylate	221	34
Atorvastatin Calcium	Atorvastatin Calcium	183	29
Eliquis	Apixaban	176	20
Sertraline Hcl	Sertraline Hcl	160	23
Trazodone Hcl	Trazodone Hcl	151	28
Potassium Chloride	Potassium Chloride	143	16
Gabapentin	Gabapentin	139	27
Tramadol Hcl	Tramadol Hcl	138	24
Escitalopram Oxalate	Escitalopram Oxalate	136	19
Lisinopril	Lisinopril	126	17
Quetiapine Fumarate	Quetiapine Fumarate	124	25
Losartan Potassium	Losartan Potassium	123	21
Famotidine	Famotidine	119	17
Latanoprost	Latanoprost	115	17
Duloxetine Hcl	Duloxetine Hcl	99	suppressed
Diclofenac Sodium	Diclofenac Sodium	98	31
Metoprolol Succinate	Metoprolol Succinate	97	22
Oxycodone Hcl	Oxycodone Hcl	94	35
Omeprazole	Omeprazole	87	16
Xarelto	Rivaroxaban	81	suppressed
Mirtazapine	Mirtazapine	78	15
Venlafaxine Hcl Er	Venlafaxine Hcl	77	suppressed
Donepezil Hcl	Donepezil Hcl	70	11
Levetiracetam	Levetiracetam	69	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	63	11
Metformin Hcl	Metformin Hcl	62	11
Citalopram Hbr	Citalopram Hydrobromide	57	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	56	11
Pantoprazole Sodium	Pantoprazole Sodium	53	11
Memantine Hcl	Memantine Hcl	51	suppressed
Carvedilol	Carvedilol	47	suppressed
Simvastatin	Simvastatin	47	suppressed
Alendronate Sodium	Alendronate Sodium	44	suppressed
Olanzapine	Olanzapine	43	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	12
Doxycycline Hyclate	Doxycycline Hyclate	38	23
Hydrochlorothiazide	Hydrochlorothiazide	37	suppressed
Prednisone	Prednisone	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	13
Jardiance	Empagliflozin	36	suppressed
Finasteride	Finasteride	33	suppressed
Methocarbamol	Methocarbamol	33	13
Tamsulosin Hcl	Tamsulosin Hcl	33	11
Carbidopa-Levodopa	Carbidopa/Levodopa	32	suppressed
Nystatin	Nystatin	32	20
Calcitonin-Salmon	Calcitonin,salmon,synthetic	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	30	suppressed
Timolol Maleate	Timolol Maleate	30	suppressed
Trimethoprim	Trimethoprim	29	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	18
Myrbetriq	Mirabegron	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Lorazepam	Lorazepam	24	14
Rasagiline Mesylate	Rasagiline Mesylate	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	17
Bupropion Xl	Bupropion Hcl	23	suppressed
Cephalexin	Cephalexin	23	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Risperidone	Risperidone	23	suppressed
Topiramate	Topiramate	23	suppressed
Allopurinol	Allopurinol	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	18	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	18	suppressed
Estradiol	Estradiol	17	suppressed
Lamotrigine	Lamotrigine	17	suppressed
Torsemide	Torsemide	17	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Lithium Carbonate	Lithium Carbonate	15	suppressed
Nystop	Nystatin	15	13
Ondansetron Hcl	Ondansetron Hcl	15	15
Rosuvastatin Calcium	Rosuvastatin Calcium	15	suppressed
Ulticare Safety Pen Needle	Pen Needle, Diabetic, Safety	15	suppressed
Baclofen	Baclofen	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	14	12
Meclizine Hcl	Meclizine Hcl	14	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	14	suppressed
Valsartan	Valsartan	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Erythromycin	Erythromycin Base	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Fentanyl	Fentanyl	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nyamyc	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error